NASDAQ:VTVT

Vtv Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy VTVT

*Your capital is at risk

$32.94

-0.0600 (-0.182%)

At Close: Jun 03, 2026

vTv Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 18.24M and sold 235.34K VTVT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	18.24M shares
● Sell	235.34K shares
96% Buy Activity Moderate Positive Correlation
Buy Signal High Confidence Sep 03, 2025 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 100. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (96% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 25, 2024 Buy	Director stock option (right to buy) A-Award	Spiegelman Daniel K Director	Director	6 000 Value: $103.3K
Jun 25, 2024 Buy	Non- Qualified Stock Option (right to buy) A-Award	Baker Bros. Advisors Lp Director	Director	983 Value: $16.9K
Jun 25, 2024 Buy	Non- Qualified Stock Option (right to buy) A-Award	Baker Bros. Advisors Lp Director	Director	6 000 Value: $103.3K
Jun 11, 2024 Buy	Common Stock J-Other	Spiegelman Daniel K	Director	0 Value: $0
Jun 11, 2024 Buy	Common Stock J-Other	Spiegelman Daniel K	Director	0 Value: $0
Mar 13, 2024 Buy	Director stock option (right to buy) A-Award	Phillips Anne M. Director	Director	3 750 Value: $60.2K
Mar 13, 2024 Buy	Director stock option (right to buy) A-Award	Phillips Anne M. Director	Director	3 750 Value: $60.2K
Mar 13, 2024 Buy	Common Stock J-Other	Phillips Anne M.	Director	0 Value: $0
Mar 13, 2024 Buy	Common Stock J-Other	Phillips Anne M.	Director	0 Value: $0
Mar 05, 2024 Buy	Pre- Funded Warrants (Right to Buy) A-Award	Samsara Biocapital Gp, Llc 10 Percent Owner	10% Owner	58 885 Value: $589
Mar 05, 2024 Sell	Class A Common Stock J-Other	Samsara Biocapital Gp, Llc 10 Percent Owner	10% Owner	58 836 Value: $588
Mar 05, 2024 Buy	Pre- Funded Warrants (Right to Buy) A-Award	Akkaraju Srinivas	Director	58 885 Value: $589
Mar 05, 2024 Sell	Class A Common Stock D-Return	Akkaraju Srinivas	Director	58 836 Value: $588
Mar 05, 2024 Sell	Class A Common Stock D-Return	Akkaraju Srinivas	Director	58 836 Value: $588
Mar 05, 2024 Buy	Pre- Funded Warrants (Right to Buy) A-Award	Akkaraju Srinivas	Director	58 885 Value: $589
Mar 05, 2024 Sell	Class A Common Stock J-Other	Samsara Biocapital Gp, Llc 10 Percent Owner	10% Owner	58 836 Value: $588
Mar 05, 2024 Buy	Pre- Funded Warrants (Right to Buy) A-Award	Samsara Biocapital Gp, Llc 10 Percent Owner	10% Owner	58 885 Value: $589
Feb 27, 2024 Buy	Stock Option (Right to Buy) A-Award	Akkaraju Srinivas	Director	3 750 Value: $31.9K
Feb 27, 2024 Buy	Director stock option (right to buy) A-Award	Al-marzooqi Fahed Director	Director	4 055 Value: $47.9K
Feb 27, 2024 Buy	Employee stock option (right to buy) A-Award	Sekhri Paul J President And CEO	CEO / President	89 212 Value: $1.05M
Feb 27, 2024 Buy	Employee stock option (right to buy) A-Award	Tuch Steven L. Chief Financial Officer	C-Suite Officer	62 159 Value: $734.1K
Feb 27, 2024 Buy	Employee stock option (right to buy) A-Award	Tuch Steven L. Chief Financial Officer	C-Suite Officer	62 159 Value: $734.1K
Feb 27, 2024 Buy	Employee stock option (right to buy) A-Award	Sekhri Paul J President And CEO	CEO / President	89 212 Value: $1.05M
Feb 27, 2024 Buy	Director stock option (right to buy) A-Award	Al-marzooqi Fahed Director	Director	4 055 Value: $47.9K
Feb 27, 2024 Buy	Stock Option (Right to Buy) A-Award	Akkaraju Srinivas	Director	3 750 Value: $31.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT VTV THERAPEUTICS INC.

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is a...

Read Full Profile Here